Valneva Expands its Commercial Operations with the Opening of its French Commercial Office
Saint-Herblain (France), January 9, 2020 – Valneva SE (“Valneva” or “the Company”) today announced a further expansion of its global commercial infrastructure with the opening of a French commercial office in Lyon. The fully owned commercial subsidiary, Valneva France SAS, will take direct control of sales and marketing of IXIARO® and DUKORAL® in France with the aim of accelerating sales growth of the vaccines.
Franck Grimaud, Chief Business Officer of Valneva, commented, “Since regaining global distribution rights of our Japanese encephalitis vaccine in 2015, we have continued to expand our commercial infrastructure in key travel markets. This allowed us to more than double our sales since 2015. Based on the deep experience that we have built and by giving focus through a dedicated sales & marketing team, we expect to increase penetration and sales in France.”
Valneva France SAS will be Valneva’s sixth commercial country operation. The Company currently has direct commercial presence in the United States, Canada, the Nordic Countries, the United Kingdom and Austria.
About Valneva SE
Valneva is a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs. Valneva’s portfolio includes two commercial vaccines for travelers: IXIARO®/JESPECT® indicated for the prevention of Japanese encephalitis and DUKORAL® indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by ETEC. The Company has various clinical-stage vaccines in development including unique vaccines against Lyme disease and chikungunya. Valneva has operations in Austria, Sweden, the United Kingdom, France, Canada and the US with approximately 490 employees. More information is available at www.valneva.com.
Valneva Investor and Media Contacts
Laetitia Bachelot-Fontaine
Global Head of Investor Relations &
Corporate Communications
M +33 (0)6 4516 7099
investors@valneva.com
Teresa Pinzolits
Corporate Communications Specialist
T +43 (0)1 20620 1116
communications@valneva.com